Cargando…

Minimal Change Disease Associated With Durvalumab

Detalles Bibliográficos
Autores principales:	Toda, Masataro G., Fujii, Kentaro, Kato, Ai, Yoshifuji, Ayumi, Komatsu, Motoaki, Amino, Yoshiaki, Kitazono, Satoru, Hashiguchi, Akinori, Ryuzaki, Munekazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484110/ https://www.ncbi.nlm.nih.gov/pubmed/34622115 http://dx.doi.org/10.1016/j.ekir.2021.08.021

Ejemplares similares

Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19
por: Toda, Masataro, et al.
Publicado: (2022)

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022)

Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022)

Chryseobacterium indologenes Peritonitis in a Peritoneal Dialysis Patient: A Case Report and Review of Literature
por: Miyakawa, Akira, et al.
Publicado: (2023)

Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients
por: Toda, Masataro, et al.
Publicado: (2021)

A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma
por: Kato, Ai, et al.
Publicado: (2022)

Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis
por: Toda, Masataro, et al.
Publicado: (2023)

Glomerulonephritis Caused by Bartonella spp. Infective Endocarditis: The Difficulty and Importance of Differentiation from Anti-neutrophil Cytoplasmic Antibody-related Rapidly Progressive Glomerulonephritis
por: Yoshifuji, Ayumi, et al.
Publicado: (2021)

IgA vasculitis and polymyalgia rheumatica induced by durvalumab
por: Casafont-Solé, Ivette, et al.
Publicado: (2020)

Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

Durvalumab: First report of minimal change disease: case report
Publicado: (2022)

Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination
por: Uwamino, Yoshifumi, et al.
Publicado: (2023)

T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis
por: Yoshifuji, Ayumi, et al.
Publicado: (2023)

COVID-19 vaccine induced interstitial lung disease
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

A case of EGFR mutation-positive lung adenocarcinoma in which the T790M allele fraction was increased by repeated EGFR-TKI treatment
por: Kimura, Hideharu, et al.
Publicado: (2019)

Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
por: D’Agati, Vivette D., et al.
Publicado: (2021)

Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
por: Tan, Shuguang, et al.
Publicado: (2017)

Post-vaccinal minimal change disease
por: Weijers, Jari, et al.
Publicado: (2021)

Kimura Disease Associated with Minimal Change Disease
por: Eren, Rafet, et al.
Publicado: (2021)

Posterior reversible encephalopathy syndrome in minimal change disease
por: Swarnalatha, G., et al.
Publicado: (2012)

The Treatment of Minimal Change Nephropathy and Focal Segmental Glomerulosclerosis
por: Milford, D V
Publicado: (1997)

Minimal change disease following vaccination with CoronaVac
por: Dirim, Ahmet Burak, et al.
Publicado: (2021)

Over-immunosuppression can be life threatening in minimal change disease
por: Bakul, G., et al.
Publicado: (2014)

Robotic pyeloplasty in an infant: Minimal access surgery with minimal ‘access’ to the patient
por: Dhar, Mridul, et al.
Publicado: (2019)

CD19 immunostaining of a stored paraffin-embedded vitrectomy cell block of intraocular lymphoma contributing to chimera antigen receptor T-cell therapy
por: Matsuo, Toshihiko, et al.
Publicado: (2022)

Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

Durvalumab activity in previously treated patients who stopped durvalumab without disease progression
por: Sheth, Siddharth, et al.
Publicado: (2020)

Maximum aesthetics with minimal intervention
por: Koirala, Sushil
Publicado: (2010)

Changes in heart rate in patients with type 2 diabetes mellitus after treatment with luseogliflozin: Subanalysis of placebo‐controlled, double‐blind clinical trials
por: Sano, Motoaki, et al.
Publicado: (2018)

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
por: Morlidge, Clare, et al.
Publicado: (2021)

Durvalumab: First Global Approval
por: Syed, Yahiya Y.
Publicado: (2017)

Retinal Vasculitis Secondary to Durvalumab
por: R. Andrade, Antonio, et al.
Publicado: (2020)

Durvalumab-induced Severe Gastritis
por: Otohara, Masaya, et al.
Publicado: (2021)

Clinical Observation on the Disinfection of Turbine Water System to Minimize Postoperative Complications of Minimally Invasive Tooth Extraction
por: CHENG, Qingtao, et al.
Publicado: (2015)

Novel CHP1 mutation in autosomal-recessive cerebellar ataxia: autopsy features of two siblings
por: Saito, Rie, et al.
Publicado: (2020)

Reactivation of minimal change disease and IgA nephropathy after COVID-19 vaccination
por: Leong, Leanne Ca-Yin, et al.
Publicado: (2021)

Complex-I defect with minimal manifestations
por: Finsterer, Josef, et al.
Publicado: (2014)

Anti-EJ, anti-MDA5 double-positive chronic clinically amyopathic dermatomyositis: a case report
por: Takeuchi, Yusuke, et al.
Publicado: (2018)

Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine
por: Tanaka, Fumika, et al.
Publicado: (2021)

Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
por: Kervella, Delphine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a24q1sedh4iteddmhc0phdmm74